Daihan Pharmaceutical (Korea) Performance
| 023910 Stock | KRW 26,450 250.00 0.95% |
The firm shows a Beta (market volatility) of -0.0856, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Daihan Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Daihan Pharmaceutical is likely to outperform the market. Daihan Pharmaceutical right now shows a risk of 0.95%. Please confirm Daihan Pharmaceutical coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Daihan Pharmaceutical will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Daihan Pharmaceutical CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -11.5 B |
Daihan |
Daihan Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,635,000 in Daihan Pharmaceutical CoLtd on August 28, 2024 and sell it today you would earn a total of 10,000 from holding Daihan Pharmaceutical CoLtd or generate 0.38% return on investment over 90 days. Daihan Pharmaceutical CoLtd is generating 0.0109% of daily returns and assumes 0.9541% volatility on return distribution over the 90 days horizon. Simply put, 8% of stocks are less volatile than Daihan, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Daihan Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Daihan Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Daihan Pharmaceutical CoLtd, and traders can use it to determine the average amount a Daihan Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0114
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 023910 |
Estimated Market Risk
| 0.95 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Daihan Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Daihan Pharmaceutical by adding Daihan Pharmaceutical to a well-diversified portfolio.
Daihan Pharmaceutical Fundamentals Growth
Daihan Stock prices reflect investors' perceptions of the future prospects and financial health of Daihan Pharmaceutical, and Daihan Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Daihan Stock performance.
| Return On Equity | 12.49 | |||
| Return On Asset | 0.0677 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 148.23 B | |||
| Shares Outstanding | 6 M | |||
| Price To Earning | 11.74 X | |||
| Price To Sales | 0.93 X | |||
| Revenue | 171.46 B | |||
| EBITDA | 39.72 B | |||
| Cash And Equivalents | 83.73 B | |||
| Total Debt | 14 B | |||
| Debt To Equity | 0.15 % | |||
| Cash Flow From Operations | 40.62 B | |||
| Total Asset | 272.54 B | |||
| Retained Earnings | 67.17 B | |||
| Current Asset | 75.05 B | |||
| Current Liabilities | 42.01 B | |||
About Daihan Pharmaceutical Performance
By analyzing Daihan Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Daihan Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Daihan Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Daihan Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Daihan Pharmaceutical performance evaluation
Checking the ongoing alerts about Daihan Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Daihan Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 35.0% of the company shares are owned by insiders or employees |
- Analyzing Daihan Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Daihan Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Daihan Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Daihan Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Daihan Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Daihan Pharmaceutical's stock. These opinions can provide insight into Daihan Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |